Simultaneous fMRI-PET of the opioidergic pain system in human brain

Hsiao-Ying Wey1, Ciprian Catana1, Jacob M Hooker1

  • 1Athinoula A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

Neuroimage
|August 10, 2014
PubMed

Insights

Simultaneous functional MRI-PET imaging reveals that pain activates opioid neurotransmission in the thalamus and striatum. This study links neurochemical events to hemodynamic responses, advancing brain imaging research.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Neurochemistry

Background:

  • Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) offer complementary insights into brain function.
  • While simultaneous MRI/PET has shown clinical potential, its ability to dissect neurochemically distinct components of the blood oxygenation level dependent (BOLD) functional MRI (fMRI) signal remains underexplored.

Purpose of the Study:

  • To investigate the biological relevance of concurrent functional MRI-PET imaging.
  • To determine if simultaneous fMRI-PET can dissect neurochemically distinct components of the BOLD fMRI signal.
  • To explore the relationship between endogenous opioid release and hemodynamic responses during pain.

Main Methods:

  • Acquired 16 fMRI-PET datasets from 8 healthy volunteers undergoing randomized pain and control scans.
  • Utilized dynamic PET with the opioid radioligand [(11)C]diprenorphine to measure endogenous opioid release.
  • Collected simultaneous BOLD fMRI data to capture hemodynamic responses during pain and control conditions.

Main Results:

  • Identified co-localized BOLD fMRI and [(11)C]diprenorphine PET signal changes in the thalamus and striatum during pain processing.
  • Observed a positive correlation between co-localized fMRI and PET signal changes in the thalamus.
  • Demonstrated modality-specific brain network activations alongside co-localized responses.

Conclusions:

  • Simultaneous fMRI-PET successfully links pain-induced opioid neurotransmission to hemodynamic activation in specific brain regions.
  • Findings suggest that endogenous opioid activity significantly contributes to the fMRI BOLD signal in the thalamus during pain.
  • This technique offers a powerful tool for in vivo investigation of neurotransmission's impact on neurovascular coupling in the human brain.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.1K